Cytek Biosciences (CTKB) EBT Margin Growth (1y) (2021 - 2026)
Cytek Biosciences (CTKB) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -287.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -464.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 772.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 233.00 |
| 10 | Cytek Biosciences | 580.46 Mn | 514.76 Mn | 21.25 Mn | -1,219.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,219.00 |
| Dec 31, 2025 | -2,445.00 |
| Sep 30, 2025 | -1,516.00 |
| Jun 30, 2025 | 56.00 |
| Mar 31, 2025 | -713.00 |
| Dec 31, 2024 | 1,090.00 |
| Sep 30, 2024 | 902.00 |
| Jun 30, 2024 | -214.00 |
| Mar 31, 2024 | 433.00 |
| Dec 31, 2023 | -145.00 |
| Sep 30, 2023 | -1,329.00 |
| Jun 30, 2023 | -978.00 |
| Mar 31, 2023 | -1,495.00 |
| Dec 31, 2022 | 737.00 |
| Sep 30, 2022 | -147.00 |
| Jun 30, 2022 | -1,423.00 |
| Mar 31, 2022 | -1,005.00 |
| Dec 31, 2021 | -2,499.00 |
| Sep 30, 2021 | -2,145.00 |
| Jun 30, 2021 | 974.00 |